Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%).
Ballow, M
Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%). [electronic resource] - Vox sanguinis Apr 2003 - 202-10 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
0042-9007
10.1046/j.1423-0410.2003.00286.x doi
Adult
Asthenia--chemically induced
Caprylates
Female
Glycine
Half-Life
Humans
Immunoglobulins, Intravenous--pharmacokinetics
Immunologic Deficiency Syndromes--complications
Male
Maltose
Pharmacokinetics
Therapeutic Equivalency
Treatment Outcome
Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%). [electronic resource] - Vox sanguinis Apr 2003 - 202-10 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
0042-9007
10.1046/j.1423-0410.2003.00286.x doi
Adult
Asthenia--chemically induced
Caprylates
Female
Glycine
Half-Life
Humans
Immunoglobulins, Intravenous--pharmacokinetics
Immunologic Deficiency Syndromes--complications
Male
Maltose
Pharmacokinetics
Therapeutic Equivalency
Treatment Outcome